M.E. Allison & Co’s Gilead Sciences GILD Stock Holding History

M.E. Allison & Co’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$459K	Hold	3,633	–	–	0.26%	100
2026 Q1	$506K	Hold	3,633	–	–	0.34%	80
2025 Q4	$446K	Hold	3,633	–	–	0.3%	88
2025 Q3	$403K	Hold	3,633	–	–	0.28%	90
2025 Q2	$403K	Hold	3,633	–	–	0.32%	82
2025 Q1	$407K	Hold	3,633	–	–	0.4%	75
2024 Q4	$336K	Buy	+3,633	New	+$327K	0.37%	82

Other funds holding GILD

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

M.E. Allison & Co's GILD Position: Q2 2026 in Review

M.E. Allison & Co held its Gilead Sciences (GILD) position steady in Q2 2026 at 3,633 shares worth $459K. The position accounts for 0.26% of the portfolio, ranked #100.

M.E. Allison & Co first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $506K in Q1 2026. 361 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

M.E. Allison & Co held 3,633 shares of Gilead Sciences worth $459K as of Q2 2026.
M.E. Allison & Co left its Gilead Sciences share count unchanged in Q2 2026.
Gilead Sciences made up 0.26% of M.E. Allison & Co's portfolio in Q2 2026, its #100 holding.
M.E. Allison & Co first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
M.E. Allison & Co's Gilead Sciences position peaked at $506K in Q1 2026.
361 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on M.E. Allison & Co's 13F filing for Q2 2026, filed 7 Jul 2026.